Sandborn WJ, Feagan BG, Hanauer S, Vermeire S, et al. Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study. J Crohns Colitis 2021 Jan 13. pii: 6092404. doi: 10.1093.
PMID: 33438008